336 related articles for article (PubMed ID: 23568983)
41. [A case of anti-gliadin-antibody-positive cerebellar ataxia effectively treated with intravenous immunoglobulin in which voxel-based morphometry and FineSRT were diagnostically useful].
Nanri K; Otsuka T; Takeguchi M; Taguchi T; Ishiko T; Mitoma H; Koizumi K
Rinsho Shinkeigaku; 2009 Jan; 49(1):37-42. PubMed ID: 19227895
[TBL] [Abstract][Full Text] [Related]
42. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase.
Ishida K; Mitoma H; Song SY; Uchihara T; Inaba A; Eguchi S; Kobayashi T; Mizusawa H
Ann Neurol; 1999 Aug; 46(2):263-7. PubMed ID: 10443895
[TBL] [Abstract][Full Text] [Related]
43. Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.
Petrijan T; Menih M
Cerebellum; 2017 Aug; 16(4):868-871. PubMed ID: 28321713
[TBL] [Abstract][Full Text] [Related]
44. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():168. PubMed ID: 26377319
[TBL] [Abstract][Full Text] [Related]
45. [A case of human immunodeficiency virus infection with cerebellar ataxia that suggested by an association with autoimmunity].
Nagao S; Kondo T; Nakamura T; Nakagawa T; Matsumoto S
Rinsho Shinkeigaku; 2016 Apr; 56(4):255-9. PubMed ID: 27010096
[TBL] [Abstract][Full Text] [Related]
46. [Hashimoto's encephalopathy and autoantibodies].
Yoneda M
Brain Nerve; 2013 Apr; 65(4):365-76. PubMed ID: 23568984
[TBL] [Abstract][Full Text] [Related]
47. Absence of anti-Purkinje cell antibodies in patients with cerebellar ataxia following falciparum malaria.
de Silva HJ; Senanayake N
Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):707-9. PubMed ID: 7667718
[TBL] [Abstract][Full Text] [Related]
48. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.
Costa M; Saiz A; Casamitjana R; Castañer MF; Sanmartí A; Graus F; Jaraquemada D
Clin Exp Immunol; 2002 Sep; 129(3):471-8. PubMed ID: 12197888
[TBL] [Abstract][Full Text] [Related]
49. Low-titer anti-GAD-antibody-positive cerebellar ataxia.
Nanri K; Niwa H; Mitoma H; Takei A; Ikeda J; Harada T; Okita M; Takeguchi M; Taguchi T; Mizusawa H
Cerebellum; 2013 Apr; 12(2):171-5. PubMed ID: 22923147
[TBL] [Abstract][Full Text] [Related]
50. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
Abele M; Weller M; Mescheriakov S; Bürk K; Dichgans J; Klockgether T
Neurology; 1999 Mar; 52(4):857-9. PubMed ID: 10078741
[TBL] [Abstract][Full Text] [Related]
51. Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias.
Mitoma H; Honnorat J; Yamaguchi K; Manto M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668612
[TBL] [Abstract][Full Text] [Related]
52. Nonparaneoplastic autoimmune cerebellar ataxias.
Joubert B; Honnorat J
Curr Opin Neurol; 2019 Jun; 32(3):484-492. PubMed ID: 30694927
[TBL] [Abstract][Full Text] [Related]
53. Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies.
Muñiz-Castrillo S; Vogrig A; Joubert B; Pinto AL; Gonçalves D; Chaumont H; Rogemond V; Picard G; Fabien N; Honnorat J
Cerebellum; 2020 Oct; 19(5):715-721. PubMed ID: 32592031
[TBL] [Abstract][Full Text] [Related]
54. Neurological Syndromes Associated with Anti-GAD Antibodies.
Dade M; Berzero G; Izquierdo C; Giry M; Benazra M; Delattre JY; Psimaras D; Alentorn A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456344
[TBL] [Abstract][Full Text] [Related]
55. Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia.
Mirabelli-Badenier M; Morana G; Pinto F; Uccelli A; Veneselli E; Battaglia FM; Biancheri R; Baglietto MG; Vincent A; Mancardi MM
Arch Neurol; 2012 Aug; 69(8):1064-6. PubMed ID: 22507885
[TBL] [Abstract][Full Text] [Related]
56. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
Vulliemoz S; Vanini G; Truffert A; Chizzolini C; Seeck M
J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):187-9. PubMed ID: 17229747
[TBL] [Abstract][Full Text] [Related]
57. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.
Nanri K; Okita M; Takeguchi M; Taguchi T; Ishiko T; Saito H; Otsuka T; Mitoma H; Koizumi K
Intern Med; 2009; 48(10):783-90. PubMed ID: 19443972
[TBL] [Abstract][Full Text] [Related]
58. A case report of plasma exchange therapy in non-paraneoplastic cerebellar ataxia associated with anti-Yo antibody.
Meloni C; Iani C; Dominijanni S; Arciprete F; Cipriani S; Caramiello MS; Tozzo C; Lombardo PA; Tatangelo P; Cecilia A; Straccialano E; Casciani CU
Ther Apher Dial; 2004 Dec; 8(6):500-2. PubMed ID: 15663551
[TBL] [Abstract][Full Text] [Related]
59. New autoantibody mediated disorders of the central nervous system.
Lang B; Dale RC; Vincent A
Curr Opin Neurol; 2003 Jun; 16(3):351-7. PubMed ID: 12858073
[TBL] [Abstract][Full Text] [Related]
60. Membranous nephropathy and cerebellar degeneration with anti-GAD antibodies in type 2 diabetes mellitus.
Folli F; Daniele G; Werner S; Kamath S; Munera JV; Abboud H; Fanti P
Acta Diabetol; 2015 Oct; 52(5):897-903. PubMed ID: 25753172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]